Group 1: R&D and Market Strategy - The company plans to enhance its R&D capabilities by focusing on three main technology platforms: scaffold materials, factors, and cells, aiming to strengthen its position in the high-barrier III class implantable medical device sector [4] - The company aims to deepen its market presence by consolidating existing channels and core brands, driving product revenue growth, and expanding its product matrix to enhance synergy [4] Group 2: Product Advantages and Market Promotion - The active biological bone product has shown excellent performance in clinical applications, combining effectiveness and safety, which helps alleviate concerns regarding BMP products among doctors [5] - The company has successfully participated in bulk procurement for its membrane products across 24 provinces, maintaining a complete record of winning bids [5] Group 3: Future Product Development and International Expansion - The calcium silicate bioceramic bone repair material is designed to promote bone regeneration and has the potential for customized production, with differentiated marketing strategies planned to maximize profitability [6] - The company is exploring opportunities for international market expansion, with plans to increase overseas revenue [6] Group 4: R&D Investment Planning - The company’s R&D investment strategy is aligned with strategic needs, ensuring that investments support overall growth and product development [6]